Jazz pays $1bn for rare disease drug developer Gentium
Dublin pharma group continues expansion in specialty therapy sector
Jazz Pharma reported to be seeking $757.2m to refinance debt
Advisors for Dublin-based niche drug business hold meeting in New York today
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices